Ten Months On, Abbott, Wockhardt Terminate Deal For Nutritional Business

MUMBAI - Pharmaceuticals-to-diagnostics giant Abbott and debt-ridden Indian drug maker Wockhardt jointly agreed to call off the $130 million deal for a nutritional business that the two had announced barely 10 months ago

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip